ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

292
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Refresh
bullishWuxi Biologics
01 Sep 2020 18:25

Wuxi Biologics Placement - Another One Before Lock-Up, but Just in Time for the Index Inclusion

Wuxi Biologics (Cayman) Inc (2269 HK) has seen a total of ten placements since listing in Jun 2017. We've covered all of the deals. Given that the...

Logo
414 Views
Share
29 Aug 2020 07:18

Asia Short Interest Weekly: Sunny Optical, Alibaba, Anta, KDDI, M3, Square Enix, Samsung, Largan

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
268 Views
Share
17 Aug 2020 09:14

Who Will Buy SamE Stake Potentially Sold by Samsung Life? Samsung C&T or SamE?

Samsung C&T is one of the most likely candidates to purchase additional stakes in Samsung Electronics. One of the strategies that Samsung...

Logo
245 Views
Share
16 Aug 2020 07:37

Asia Short Interest Weekly: AliHealth, Meituan, SunnyOptical, WuXi Apptec, Canon, Lasertec, Seegene

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
294 Views
Share
bullishWuxi Biologics
16 Jul 2020 10:21

Wuxi Biologics - Recap/Learnings from past Placements

Wuxi Biologics (Cayman) Inc (2269 HK) has seen a total of ten placements since listing in Jun 2017. We've covered all of the deals. Given that the...

Logo
469 Views
Share
x